Resources

Type of publications
Regions
Diseases

5192 results found

2022 ∙ Du, Y. Chen, L. Shi, Y.

Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Adolescents, Children, and Infants: A Systematic Review and Meta-Analysis

  • Children
  • Adolescents
  • COVID-19
  • Safety
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2022 ∙ Ledda, C. Costantino, C. Motta, G. Cunsolo, R. Stracquadanio, P. Liberti, G. Maltezou, H. C. Rapisarda, V.

SARS-CoV-2 mRNA Vaccine Breakthrough Infections in Fully Vaccinated Healthcare Personnel: A Systematic Review

  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Ssentongo, P. Ssentongo, A. E. Voleti, N. Groff, D. Sun, A. Ba, D. M. Nunez, J. Parent, L. J. Chinchilli, V. M. Paules, C. I.

SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Omolaoye, T. S. Velilla, P. A. Moncada López, J. S. du Plessis, S. S. Cardona Maya, W. D.

SARS-CoV-2 Vaccine Effects on Semen Parameters: A Systematic Review and Meta-Analysis

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Ippolito, S. Gallo, D. Rossini, A. Patera, B. Lanzo, N. Fazzino, G. F. M. Piantanida, E. Tanda, M. L.

SARS-CoV-2 vaccine-associated subacute thyroiditis: insights from a systematic review

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Avallone, G. Quaglino, P. Cavallo, F. Roccuzzo, G. Ribero, S. Zalaudek, I. Conforti, C.

SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ De Rose, D. U. Salvatori, G. Dotta, A. Auriti, C.

SARS-CoV-2 Vaccines during Pregnancy and Breastfeeding: A Systematic Review of Maternal and Neonatal Outcomes

  • Pregnant women
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Nie, X. Xu, L. Bai, Y. Liu, Z. Liu, Z. Farrington, P. Zhan, S.

Self-controlled case series design in vaccine safety: a systematic review

  • All age groups
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Yin, J. Chen, Y. Li, Y. Zhang, X. Wang, C.

Seroconversion rate after COVID-19 vaccination in patients with solid cancer: A systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Verleye, A. Wijtvliet, V. Abrams, S. Hellemans, R. Bougrea, R. Massart, A. Pipeleers, L. Wissing, K. M. Ariën, K. K. De Winter, B. Y. Van Damme, P. Abramowicz, D. Ledeganck, K. J.

Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis

  • Adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...